Clinical Laserthermia Systems AB (publ)

OM:CLS B Stock Report

Market Cap: SEK 83.6m

Clinical Laserthermia Systems Balance Sheet Health

Financial Health criteria checks 4/6

Clinical Laserthermia Systems has a total shareholder equity of SEK58.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK68.5M and SEK10.3M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 15.58m
EquitySEK 58.20m
Total liabilitiesSEK 10.28m
Total assetsSEK 68.49m

Recent financial health updates

Recent updates

We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Jan 03
We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Aug 26
Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Mar 01
Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Financial Position Analysis

Short Term Liabilities: CLS B's short term assets (SEK31.3M) exceed its short term liabilities (SEK10.1M).

Long Term Liabilities: CLS B's short term assets (SEK31.3M) exceed its long term liabilities (SEK223.0K).


Debt to Equity History and Analysis

Debt Level: CLS B is debt free.

Reducing Debt: CLS B has no debt compared to 5 years ago when its debt to equity ratio was 99.6%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CLS B has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CLS B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.5% each year


Discover healthy companies